Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05990426 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

Study acronym: FAST
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Aug 2026 → Aug 2027
See other at-risk trials from Northwestern University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 2026 to Aug 2027
    • Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Study description revised
  2. Primary completion date: Aug 2025 to Aug 2026
    • Site contact updated
    v4
  3. Site contact updatedv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 15, 2023 to Oct 16, 2023
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Endometrial cancer is the most common gynecologic cancer and ovarian cancer is the most lethal. The management of both advanced cancers is a combination of chemotherapy and surgery. Standard of care chemotherapeutic treatment for uterine and ovarian cancers is toxic and severely disruptive to the patient's quality of life with the potential for devastating short and long-term side effects. The role of fasting and ketogenic diets has been evaluated in a mixed cancer population and previously shown to be safe. There is no data specifically addressing the impact of a fasting diet regimen on side effects of chemotherapy during treatment for ovarian and endometrial cancers in the front-line setting. The information gathered from this study will inform future trials about the role of time-restricted eating and its impact on side-effects associated with chemotherapy as well as its role in improvement of quality of life for women afflicted with these debilitating diseases.
Trial Details
NCT Number NCT05990426
Lead Sponsor Northwestern University
Conditions
(from sponsor)		 Ovary Cancer, Endometrial Cancer, Uterine Cancer
Related terms Endometrial Neoplasms, Intermittent Fasting, Ovarian Neoplasms, Peripheral Nervous System Diseases, Uterine Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov